Spatial Genomics & Transcriptomics Market: Growth, Size, Share, and Trends

Report Code BT 7790
Published in Dec, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Spatial Genomics & Transcriptomics Market by Product (Instruments, Consumables, Services), Technique (Transcriptomics (IHC, ISH), Genomics (LCM), Service Type (Sample Prep, Sequencing), Application (Translation Research (Cancer)) - Global Forecast to 2029

Overview

The global spatial genomics & transcriptomics market, valued at US$532.7 million in 2023, is forecasted to grow at a robust CAGR of 12.4%, reaching US$554.5 million in 2024 and an impressive US$995.7 million by 2029. Market growth is attributed to factors such as increasing adoption of spatial genomics and transcriptomics in drug discovery and development, increasing pharmaceutical R&D investments and public-private funding, introduction of technologically advanced instruments for spatial genomics analysis, and the introduction of novel products are driving the growth of the spatial genomics & transcriptomics market. However, the faces several challenges due to high initial capital investments and technical complexity and expertise gap.

Spatial Genomics & Transcriptomics Market – Global Forecast and Key Opportunities to 2029

Attractive Opportunities in the Spatial Genomics & Transcriptomics Market

North America

Growth in the North American spatial genomics & transcriptomics market can be attributed to the presence of well-established and emerging biotechnology companies, growing emphasis on personalized medicines, and rising government funding.

The increasing adoption of spatial genomics and transcriptomics in drug discovery and development and increasing pharmaceutical R&D investments and public-private funding are driving the market growth.

Increasing use of spatial omics for biomarker identification and increasing demand for precision medicines and targeted drug development present significant growth opportunities for this market.

High initial capital investments & maintenance costs and technical complexity and expertise gap limit the growth of this market.

Globally, North America is the largest market for gene spatial genomics & transcriptomics and this trend is expected to continue during the forecast period.

Global Spatial Genomics & Transcriptomics Market Dynamics

DRIVER: Rising pharmaceutical R&D expenditures and public-private financing

The pharmaceutical R&D industry has traditionally been capital-intensive because of long development periods and approval cycles. Governments view R&D as an important investment for a country's development, global competitiveness, and social good. As such, R&D spending and financing have been constantly rising. Increasing investments in spatial genomics and transcriptomics by market players and research institutes, along with the support of investors and venture capitalists, are expected to propel the use of innovative technologies, such as spatial genomics. With the growing need for early diagnosis and remedial treatment of life-threatening diseases, there has been an increase in the number of R&D programs to develop innovative products and technologies to curb such diseases; this has guaranteed consistent private investments, government funding, and grants within the spatial genomics and transcriptomics sectors. For example, Moleculent AB in June 2024 reported closing of the oversubscribed USD 25.0 million Series A financing to drive spatial mapping of cell-cell communication. In January 2023, Nature's Array, a startup in the spatial transcriptomics area, received seed funding amounting to USD 10.0 million. The funds will aid the company to advance its novel method for dissecting tissue architecture and gene expression and develop research in different areas, including cancer. In August 2022, Revolutionary Genomics has raised USD 50.0 million in funding for its Series A in developing spatial genomics technology. This funding provided more depth in understanding diseases and supported the efforts of finding drugs while exploiting the value of spatial data within genomic studies. In March 2022, Spatial Genomics Inc. concentrated in spatial genomics and secured USD 30.0 million in a Series A round. The proceeds were to be used in expansion of its capabilities in gene expression and tissue architecture studying, which are critical in understanding complex biological systems and diseases. In February 2022, Fulgent Genetics announced a strategic investment in Spatial Genomics, Inc. The company develops sequential fluorescence in situ hybridization (seqFlSH) technology. Fulgent Genetics invested up to USD 40 million to lead Spatial genomics' Series A financing, which totals approximately USD 56 million and includes investments by 12 West Capital and other investors.

RESTRAINT: Highly expensive capital investments and service charges at the outset

One of the most significant limitations for the demand of spatial genomics and transcriptomics in small and medium -sized research institutes has been the highly expensive nature of capital investment to get technologically advanced systems along with the software. Improved instruments are much costlier because their development process is pretty expensive. For example, during 2024, for an Illumina Nova Seq system. The cost of a NextSeq 500 instrument from Illumina is NUSD 125,000. The high investment cost has led to the lower adoption of transcriptomic technologies in small and medium-sized research labs. Researchers are hesitant to invest in new technologies, especially given the limited evidence of measurable returns on investment. In addition, the outcome of the studies may not always be as expected, leading to unsatisfactory results or process re-runs, thus raising the general cost of the study. Companies use available structural data and trial-and-error approaches to identify the compounds that activate or inhibit targets. All procedures require significant laboratory hours, thus making the cost of testing per sample high. Such expensive costs of equipment and reagents make it difficult for developing countries to venture into the field of transcriptomics. The costs associated with this technology are too high, which has led to the lower-than-expected adoption of transcriptomic technologies worldwide. Instrument maintenance is costly and includes spares, chemicals, consumables, and timely servicing. Highly trained manpower is also needed for using these instruments. Though the cost of transcriptomic technologies is coming down, it is still pretty high for small and medium-sized research laboratories. The huge investment required in the preliminary phase acts as a restraining factor and limits the deployment of transcriptomic technologies in the market. Growth in the investment in research fund and government support towards research on transcriptomics might address this in the future years.

 

OPPORTUNITY: Increasing use of spatial omics for biomarker identification

Biomarker identification and clinical applications have simplified drug discovery and development procedures in evaluating drug toxicity and efficacy. Besides, biomarkers for diseases such as cancer, CVDs, and neurological diseases help better understand the disease pathway and progression. The discovery of new biomarkers in diagnosing various diseases, especially cancer diagnosis, has brought revolutionary medical changes. Furthermore, continuous developments in sequencing technologies have increased the efficiency of biomarkers in disease detection and their utilization in disease diagnoses.

The increasing demand for biomarkers is expected to boost the transcriptomics technologies market. The substantial addressable market for biomarkers and the growing applications of transcriptomics in biomarker discovery are expected to provide significant growth opportunities for the overall market for the next few years. According to the International Agency for Research on Cancer (IARC), there were close to 20 million new cases of cancer in the year 2022 (including nonmelanoma skin cancers [NMSCs]) alongside 9.7 million deaths from cancer (including NMSC). The rising prevalence of cancer has compelled researchers to focus on identifying markers that distinguish between indolent and aggressive cancers.

Multiplex spatial tissue analysis (MSTA) is an emerging technique to address the needs of researchers intending to interrogate the tumor microenvironment at unprecedented levels of detail and granularity. MSTA refers to methodologies for assessing multiple biomarkers (protein and nucleic acid markers) at specific locations within a tissue sample. With the expansion of various novel approaches, it is now possible to assess from dozens up to >1,000 RNA and protein markers (at least in regions of interest) simultaneously while preserving (some degree of) spatial context.

CHALLENGES: Dearth of skilled professionals

Spatial genomics and transcriptomics are new areas of omics research. The global development of spatial transcriptomics research has been concentrated in the US and other developed countries in Europe. Moreover, even in these countries, the scope of spatial transcriptomics research is relatively small compared to other areas of omics research. Due to this, only limited research expertise is available in this field. Transcriptome analysis comprises sophisticated methods to study biological entities within a laboratory setup. It involves labor-intensive techniques and skilled professionals such as researchers and technicians performing experiments, setting up and running tests and experiments, making observations, obtaining results, and analyzing data. Lack of knowledge regarding the underlying scientific principles and the right choice of technique may result in several direct and indirect expenses, increasing the workload and time pressure on researchers and service providers. Thus, there is a need for highly skilled personnel for method development, validation, operation, and troubleshooting activities. CodeWizardsHQ estimates that, almost 4x quicker than non-STEM professions, STEM employment are expected to rise 10.8% between 2022 and 2032. By 2025, the US needs Ell around 3.5 million jobs, but a skills shortage would cause 2 million of them to be unmet. Moreover, according to the US Bureau of Labor Statistics, the last decade has seen considerable concern regarding a shortage of STEM workers to meet market demands. Although the demand for STEM skills rose by 20% from 2009 to 2015, the US Bureau of Labor Statistics mentions a shortage of skilled medical professionals in medical research, pharmaceuticals, and sciences. As the early adopters of newer technologies in life sciences, European countries face similar challenges due to a shortage of graduates in STEM fields. The share of STEM graduates has fallen from 24.8% to 22.7% in the last decade. The lack of clarity around the outcomes of transcriptomic research and the high equipment cost have led to the lower adoption of transcriptomic technologies, thereby limiting the spread of technical knowledge related to transcriptomics research.

Global Spatial Genomics & Transcriptomics Market Ecosystem Analysis

Raw material suppliers, product and service providers, end users and regulatory bodies make up the varied network of components in the spatial genomics and transcriptomics market ecosystem. By working together, these researchers speed and implement spatial genomics technologies, therefore promoting innovation and accelerating the transfer from the lab to useful applications in individualized medicine and beyond. Suppliers of raw materials in the spatial genomics and transcriptomics market facilitate product development and manufacture by the provision of essential components, including high-quality reagents, enzymes, primers, and other consumables critical for genomic assays and spatial analytic technologies.

The spatial genomics and transcriptomic ecosystem depends much on commercial enterprises offering products and services. Among them are big companies as 10x Genomics, Illumina, and NanoString Technologies. Such companies create and produce analytical tools, spatial transcriptomics tools, and novel sequencing technologies. Those people who really apply the tools of spatial genomics and transcriptomics in another field represent the key component. Among these are research and academic institutions, CROs and CDMOs, biotechnology and pharmaceutical companies.

Regulatory agencies guarantee that products derived from spatial genomics and transcriptomics are safe and useful in illness treatment. For instance, drugs derived from genetic research and diagnostic tests are approved by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA).

Spatial Genomics & Transcriptomics Market
 

In the spatial genomics and transcriptomics market in 2023 the product segment held the largest share of offering segment.

Spatial genomics and transcriptomics market is divided by Segments- products and services. Products will have the highest share in 2023. The part of the spatial genomics and transcriptomics market is instruments & software as well as consumables. Imaging devices, sequencing tools, and data analysis software in the section Tools in Instruments & Software help to gather and interpret spatially resolved genomic data. The emergence of this field is clarified by the increasing need in research for high-resolution spatial gene and protein expression data. Key drivers influencing the market expansion include consumables and the expanding uses of spatial genomics and transcriptomics in drug research and development as well as in biomarker identification. Moreover, different software users—especially for spatial analysis and new product launch—are investing more, which facilitates the growth of this market. The consumables category in the spatial genomics and transcriptomics market encompasses essential reagents, gene panels, assay kits, and additional supplies for sample preparation and data processing. NanoString Technologies, Inc. (US) provides a range of consumables for its GeoMx and nCounter platforms, featuring specialized panels for oncology, neuroscience, cardiovascular disease, and immunology research. In August 2022, Massachusetts General Hospital (US) employed GeoMx consumables alongside its Human Whole Transcriptome Atlas to delineate pancreatic cancer at the molecular level. The demand for improved reproducibility and high-quality data gathering to enhance spatial genomics research in oncology and precision medicine is propelling the consumables market.

In 2023, transcriptomics technique accounted for the highest share in the market.

Based on technique, segmentation of the spatial genomics and transcriptomics market is achieved by spatial transcriptomics and spatial genomics approaches. Driven by increasing acceptance of in situ sequencing technologies and increasingly broad applications in disease research, the segment of spatial transcriptomics held the largest proportion of spatial genomics and transcriptomics market in 2023. Spatial transcriptomics is further analyzed across immunohistochemistry (IBC), immunofluorescence (IF), microscopy-based RNA imaging, In-situ hybridization (ISH), laser Capture microdissection (LCM), RNA sequencing and other transcriptomics techniques. Using spatial transcriptomics, one maps gene expression within the spatial context of a tissue. Combining histology and molecular data indicates how genes are expressed in certain tissue countries or regions, therefore guiding understanding of cellular architecture, function, and disease progression. Applications of spatial transcriptomics are many in clinical and scientific spheres. In cancer research, it aids in the identification of tumor microenvironments and cell-to---cell interactions, so guiding focused therapy. In neuroscience, it guides brain Country/Regions toward comprehension of intricate neural networks. It also helps identify biomarkers, advances diagnostics, and creates individualized treatments for many ailments.

The spatial genomics and transcriptomics market in 2023 was dominated by North America.

Six main regions are covered in the spatial genomics & transcriptomics market: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. While Europe is the second biggest regional market for spatial genomics & transcriptomics in 2023, North America is the largest. Together with key players in the spatial genomics and transcriptomics market, increasing focus on individualized medicine, and government financing, North America's huge share can be ascribed to the existence of established and developing biotechnology enterprises.

In order to broaden their product offers, businesses have been concentrating on mergers and acquisitions. In order to develop and market new products, as well as to further genetics research, a number of the most successful businesses in this region have acquired smaller businesses that were already producing related product lines. For example, on October 10, 2023, 10x genomes made the announcement that it had purchased Basepaws (US), a company in the United States that provides technologically enhanced health diagnostics based on genomes. The acquisition was estimated to be worth around 100.0 million USD dollars.

Nonetheless, The Asia Pacific is projected to be the fastest-growing segment of the market defined by increasing government efforts to meet rising healthcare needs, growing government investment in biotechnology, growing demand of precision medicine, rising healthcare expenditure, growing R&D expansion in important markets including India, China, and Japan, and the favorable regulatory environment in the region.

HIGHEST CAGR MARKET IN 2024
US FASTEST GROWING MARKET IN THE REGION
Spatial Genomics & Transcriptomics Market

Recent Developments of Spatial Genomics & Transcriptomics Market

  • In October 2024, 10x Genomics and Beckman Coulter Life Sciences collaborated to improve automation for single-cell assay operations.
  • In October 2024, Illumina, Inc. announced the launch of MiSeq ilOO sequencing equipment. These systems offer unrivaled benchtop speed and simplicity, advancing next-generation sequencing (NGS) in labs.
  • In September 2024, Bio-Techne announced that one of its spatial biology brands, Lunaphore, is partnering with Discovery Life Sciences (Discovery) to add Lunaphore COMET, a best-in-class spatial biology platform, to Discovery's global suite of biospecimen products and specialty lab services supporting customers with clinical research.
  • In June 2024, Bio-Rad Laboratories, Inc. launched a ddSEQ Single-Cell 3' RNA-Seq Kit and complementary Omnition analysis software for single-cell transcriptome and gene expression research.

Key Market Players

KEY PLAYERS IN THE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET INCLUDE

Want to explore hidden markets that can drive new revenue in Spatial Genomics & Transcriptomics Market?

Scope of the Report

Report Metric Details
Market size available for years 2022-2029
Base Year Considered 2023
Forecast period 2024-2029
Forecast units Value (USD Million)
Segments covered Offering, Technique, Application, Type (Service), End User (Product), End User (Service).
Geographies covered North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa

 

Key Questions Addressed by the Report

Who are the key players in the spatial genomics & transcriptomics market?
Key players in the spatial genomics & transcriptomics market include NanoString Technologies, Inc. (Bruker Spatial Biology, Inc.) (US), 10x Genomics (US), Bio-Rad Laboratories, Inc. (US), Illumina, Inc. (US), Bio-Techne (US), Standard BioTools (US), and Akoya Biosciences, Inc. (US).
Which offering segment dominates the spatial genomics & transcriptomics market?
The product segment dominated the spatial genomics & transcriptomics market by offering, its share can be attributed due to the increasing demand for high-resolution spatial gene and protein expression data in research.
Which technique segment dominated the spatial genomics & transcriptomics market?
In 2023, spatial transcriptomics dominated the spatial genomics & transcriptomics market by technique, majorly due to the increasing adoption rate of in situ sequencing techniques and broader applications in disease research.
Which type (service) segment held the largest market share of the spatial genomics & transcriptomics market?
In 2023, the sequencing & analysis services segment held the largest market share of the spatial genomics & transcriptomics market by type (service), this can be attributed to the rising demand for precise gene expression profiling in disease research and drug development.
Which application segment dominated the spatial genomics & transcriptomics market?
In 2023, translational research dominated the spatial genomics & transcriptomics market by application, majorly due to increasing funding for research in spatial genomics and transcriptomics.
Which end user (product) segment dominated the spatial genomics & transcriptomics market?
In 2023, academic & research institutes dominated the spatial genomics & transcriptomics market by end user (product), majorly due to increasing need of precise cellular insights in scientific research.
Which end user (service) segment dominated the spatial genomics & transcriptomics market?
In 2023, academic & research institutes dominated the spatial genomics & transcriptomics market by end user (service), majorly due to increasing need for tools to map cellular environments and study disease mechanisms.
What is the market size of spatial genomics & transcriptomics market?
The spatial genomics & transcriptomics market is expected to grow to USD 995.7 million by 2029 from USD 554.5 million in 2024, at a CAGR of 12.4%

 

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Spatial Genomics & Transcriptomics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table Of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
41
RESEARCH METHODOLOGY
46
EXECUTIVE SUMMARY
60
PREMIUM INSIGHTS
65
MARKET OVERVIEW
69
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Increasing adoption of spatial genomics and transcriptomics in drug discovery and development
    - Introduction of novel products
    - Increasing pharmaceutical R&D investments and public-private funding
    RESTRAINTS
    - High initial capital investments and maintenance costs
    - Technical complexity and expertise gap
    OPPORTUNITIES
    - Increasing use of spatial omics for biomarker identification
    - Growing demand for precision medicines and targeted drug development
    CHALLENGES
    - Dearth of skilled professionals
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
  • 5.4 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY KEY PLAYER, 2021–2023
    AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER, 2021–2023
    AVERAGE SELLING PRICE OF KEY PRODUCTS, BY REGION, 2021–2023
  • 5.5 SUPPLY CHAIN ANALYSIS
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 ECOSYSTEM ANALYSIS
  • 5.8 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - In-situ sequencing
    - In-situ hybridization
    - Single-cell RNA sequencing
    COMPLEMENTARY TECHNOLOGIES
    - Multi-isotope imaging mass spectrometry
    - Spatial heatmap
    - Differential gene expression analysis
    ADJACENT TECHNOLOGIES
    - Multi-omics
    - Metabolomics
    - Single-cell analysis
  • 5.9 PATENT ANALYSIS
  • 5.10 KEY CONFERENCES & EVENTS, 2025–2026
  • 5.11 REGULATORY LANDSCAPE
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    REGULATORY FRAMEWORK
  • 5.12 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF BUYERS
    BARGAINING POWER OF SUPPLIERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.13 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    KEY BUYING CRITERIA, BY END USER (PRODUCT)
  • 5.14 TRADE ANALYSIS
    IMPORT DATA FOR HS CODE 902790
    EXPORT DATA FOR HS CODE 902790
  • 5.15 INVESTMENT & FUNDING SCENARIO
  • 5.16 IMPACT OF AI/GEN AI ON SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING
103
  • 6.1 INTRODUCTION
  • 6.2 PRODUCTS
    INSTRUMENTS & SOFTWARE
    - Instruments & software to facilitate disease research by enabling detailed spatial mapping and multi-omic analyses
    CONSUMABLES
    - Better reproducible and high-quality data collection to advance spatial genomics research in oncology and precision medicine
  • 6.3 SERVICES
    INCREASING DEMAND FOR HIGH-QUALITY SPATIAL DATA IN PRECISION MEDICINE TO AUGMENT MARKET GROWTH
SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE
117
  • 7.1 INTRODUCTION
  • 7.2 SPATIAL TRANSCRIPTOMICS
    IMMUNOHISTOCHEMISTRY
    - Increasing applications in biomarker discovery and cellular interactions within tissue architecture to drive segment
    IMMUNOFLUORESCENCE
    - Advanced profiling immune-tumor microenvironments for cancer diagnosis and prognosis to propel segment growth
    MICROSCOPY-BASED RNA IMAGING
    - Better insights into molecular communication within tissue architecture to augment segment growth
    IN-SITU HYBRIDIZATION
    - High-throughput and 3D spatial gene expression analysis in cancer research and developmental biology to drive segment
    LASER CAPTURE MICRODISSECTION
    - Analysis of gene expression data from defined cellular populations to facilitate spatial mapping within tissue sections
    RNA SEQUENCING
    - In-situ RNA sequencing
    - Single-cell RNA (SC-RNA) sequencing
    - Other RNA sequencing
    OTHER SPATIAL TRANSCRIPTOMIC TECHNIQUES
  • 7.3 SPATIAL GENOMICS
    IN-SITU HYBRIDIZATION
    - Demand for high-specificity detection platforms to fuel market growth
    LASER CAPTURE MICRODISSECTION
    - Detailed insights into cellular mechanisms and molecular profiles within heterogeneous tissue samples to drive segment
    GENOMIC SEQUENCING
    - Microdissection-based sequencing
    - Chromatin accessibility sequencing
    - Other genomic sequencing
    OTHER SPATIAL GENOMIC TECHNIQUES
SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE
170
  • 8.1 INTRODUCTION
  • 8.2 SAMPLE PREPARATION SERVICES
    NEED FOR ACCURATE SPATIAL ANALYSIS OF GENE EXPRESSION WITHIN TISSUE SAMPLES TO SPUR MARKET GROWTH
  • 8.3 SEQUENCING & ANALYTICAL SERVICES
    SEQUENCING & ANALYTICAL SERVICES TO UTILIZE ADVANCED TECHNOLOGIES FOR SEQUENCING AND BIOINFORMATICS ANALYSIS
  • 8.4 DATA VISUALIZATION & ANALYSIS SERVICES
    INCREASED DEMAND FOR ADVANCED TOOLS FOR COMPLEX SPATIAL GENOMICS DATA INTERPRETATION TO SUPPORT MARKET GROWTH
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION
180
  • 9.1 INTRODUCTION
  • 9.2 TRANSLATIONAL RESEARCH
    CANCER
    - Spatial genomics and transcriptomics to map precise locations of DNA and RNA within tumor tissues in cancer research
    IMMUNOLOGY
    - Need for better understanding of immune cell interactions and tissue-specific immune responses to propel segment growth
    NEUROSCIENCE
    - Increased focus on mapping cellular diversity for analyzing brain function and dysfunction to aid market growth
    INFECTIOUS DISEASES
    - Need for enhanced understanding of pathogen-host interactions at tissue level to drive adoption
    OTHER DISEASES
  • 9.3 DRUG DISCOVERY & DEVELOPMENT
    RISING USE OF RNA-SEQ IN DISEASE MANAGEMENT DRUG DISCOVERY TO DRIVE MARKET
    SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER
SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER
201
  • 10.1 INTRODUCTION
  • 10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO TRANSFORM DISEASE RESEARCH AND STREAMLINE DRUG TARGET VALIDATION
  • 10.3 ACADEMIC & RESEARCH INSTITUTES
    FOCUS ON FOUNDATIONAL DISCOVERIES AND CELLULAR INSIGHTS ABOUT COMPLEX BIOLOGICAL SYSTEMS TO AID MARKET GROWTH
  • 10.4 CROS & CDMOS
    GROWING DEMAND FOR PRECISE SPATIAL MOLECULAR INSIGHTS TO PROPEL MARKET GROWTH
  • 10.5 CLINICAL DIAGNOSTIC LABORATRIES
    IMPROVED DIAGNOSTIC ACCURACY IN PATHOGEN DETECTION AND GENOMIC ANALYSIS TO AID MARKET GROWTH
SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER
215
  • 11.1 INTRODUCTION
  • 11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO OPTIMIZE BIOMARKER DEVELOPMENT AND IMPROVE CLINICAL TRIAL DESIGN
  • 11.3 ACADEMIC & RESEARCH INSTITUTES
    NEED FOR TOOLS FOR MAPPING CELLULAR ENVIRONMENTS AND STUDYING DISEASE MECHANISMS TO PROPEL MARKET GROWTH
  • 11.4 OTHER END USERS
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY REGION
225
  • 12.1 INTRODUCTION
  • 12.2 NORTH AMERICA
    NORTH AMERICA: MACROECONOMIC OUTLOOK
    US
    - US to dominate North American spatial genomics & transcriptomics market during forecast period
    CANADA
    - Favorable government initiatives and high incidence of infectious diseases to support market growth
  • 12.3 EUROPE
    EUROPE: MACROECONOMIC OUTLOOK
    GERMANY
    - Advanced genomics research and presence of several key companies to spur market growth
    UK
    - Increasing government funding and rising demand for new diagnostic biomarkers to aid market growth
    FRANCE
    - Increasing investments in life science R&D and rising number of biotech companies to propel market growth
    ITALY
    - Increasing focus on neuroscience and rare disease research to augment market growth
    SPAIN
    - Focus on advanced cancer research and increased need for personalized medicines to propel market growth
    REST OF EUROPE
  • 12.4 ASIA PACIFIC
    ASIA PACIFIC: MACROECONOMIC OUTLOOK
    CHINA
    - Increasing R&D spending by government and biopharma companies to propel market growth
    JAPAN
    - Favorable government policies and high R&D funding to boost market growth
    INDIA
    - Increasing collaborations between hospitals and diagnostics centers to boost market growth
    SOUTH KOREA
    - Increased research on advanced precision medicines and well-established biotechnology infrastructure to aid market growth
    AUSTRALIA
    - Strategic focus on advancing cancer research and precision oncology to boost market growth
    REST OF ASIA PACIFIC
  • 12.5 LATIN AMERICA
    LATIN AMERICA: MACROECONOMIC OUTLOOK
    BRAZIL
    - Increasing adoption of biomarkers for drug discovery & development to drive market
    MEXICO
    - Favorable funding scenario in biotechnology sector and high funding in biomanufacturing to augment market growth
    REST OF LATIN AMERICA
  • 12.6 MIDDLE EAST
    LOWER R&D INVESTMENTS AND WEAK INFRASTRUCTURAL DEVELOPMENTS TO HINDER MARKET GROWTH
    MIDDLE EAST: MACROECONOMIC OUTLOOK
  • 12.7 AFRICA
    INCREASING FUNDING AND PARTNERSHIPS IN RESEARCH SECTOR TO SUPPORT GROWTH OF BIOTECHNOLOGY INDUSTRY
    AFRICA: MACROECONOMIC OUTLOOK
COMPETITIVE LANDSCAPE
343
  • 13.1 INTRODUCTION
  • 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET
  • 13.3 REVENUE ANALYSIS, 2019−2023
  • 13.4 MARKET SHARE ANALYSIS, 2023
    SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET
    SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET
    RANKING OF KEY MARKET PLAYERS
  • 13.5 COMPANY VALUATION & FINANCIAL METRICS
    COMPANY VALUATION
    FINANCIAL METRICS
  • 13.6 BRAND/PRODUCT COMPARISON
  • 13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Region footprint
    - Offering footprint
    - Technique footprint
    - Application footprint
  • 13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    - Detailed list of key startups/SMEs
    - Competitive benchmarking of key startups/SMEs
  • 13.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES
    DEALS
    EXPANSIONS
COMPANY PROFILES
369
  • 14.1 KEY PLAYERS
    10X GENOMICS
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    BIO-TECHNE
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    NANOSTRING TECHNOLOGIES, INC. (BRUKER SPATIAL BIOLOGY, INC.)
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    STANDARD BIOTOOLS
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    ILLUMINA, INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    BIO-RAD LABORATORIES, INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    AKOYA BIOSCIENCES, INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    VISIOPHARM A/S
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    DANAHER CORPORATION
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    SEVEN BRIDGES GENOMICS
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    REVVITY
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    VIZGEN INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    VERACYTE, INC.
    - Business overview
    - Products/Services/Solutions offered
    NATERA, INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    MACROGEN INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    MILTENYI BIOTEC
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
  • 14.2 OTHER PLAYERS
    BIOMARKER TECHNOLOGIES (BMKGENE)
    ULTIVUE, INC.
    RARECYTE, INC.
    S2 GENOMICS, INC.
    ADMERA HEALTH
    SONY BIOTECHNOLOGY INC.
    CANTATA BIO
    NUCLEAI, INC.
    VISIKOL, INC.
    IONPATH, INC.
    BIOSPYDER, INC.
    SINGULAR GENOMICS SYSTEMS, INC.
    LUNAPHORE TECHNOLOGIES SA
    REBUS BIOSYSTEMS, INC.
APPENDIX
442
  • 15.1 DISCUSSION GUIDE
  • 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 15.3 CUSTOMIZATION OPTIONS
  • 15.4 RELATED REPORTS
  • 15.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS
  • TABLE 3 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: RISK ANALYSIS
  • TABLE 4 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: IMPACT ANALYSIS
  • TABLE 5 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY KEY PLAYER, 2021–2023 (USD)
  • TABLE 6 AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER, 2021–2023 (USD)
  • TABLE 7 AVERAGE SELLING PRICE OF KEY PRODUCTS, BY REGION, 2023 (USD)
  • TABLE 8 AVERAGE SELLING PRICE OF KEY PRODUCTS, BY REGION, 2022 (USD)
  • TABLE 9 AVERAGE SELLING PRICE OF KEY PRODUCTS, BY REGION, 2021 (USD)
  • TABLE 10 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: ROLE IN ECOSYSTEM
  • TABLE 11 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2021–2023
  • TABLE 12 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026
  • TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: REGULATORY SCENARIO, BY COUNTRY
  • TABLE 18 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: PORTER’S FIVE FORCES
  • TABLE 19 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%)
  • TABLE 20 KEY BUYING CRITERIA, BY END USER (PRODUCT)
  • TABLE 21 IMPORT DATA FOR HS CODE 902790, BY COUNTRY, 2021–2022 (USD MILLION)
  • TABLE 22 EXPORT DATA FOR HS CODE 902790, BY COUNTRY, 2021–2022 (USD MILLION)
  • TABLE 23 IMMUNOFLUORESCENCE QUANTITATIVE ANALYZERS IMPORT/EXPORT DATA, MARCH 2023–FEBRUARY 2024
  • TABLE 24 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 25 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 26 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY VOLUME, 2022–2029 (UNITS)
  • TABLE 27 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 28 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 29 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 30 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 31 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 32 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 33 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 34 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 35 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 36 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 37 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CONSUMABLES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 38 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 39 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 40 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 41 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 42 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 43 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 44 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 45 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 46 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 47 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 48 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 49 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 50 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 51 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 52 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 53 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 54 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 55 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 56 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 57 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 58 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 59 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOFLUORESCENCE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 60 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOFLUORESCENCE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 61 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOFLUORESCENCE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 62 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOFLUORESCENCE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 63 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOFLUORESCENCE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 64 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR MICROSCOPY-BASED RNA IMAGING, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 65 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR MICROSCOPY-BASED RNA IMAGING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 66 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR MICROSCOPY-BASED RNA IMAGING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 67 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR MICROSCOPY-BASED RNA IMAGING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 68 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR MICROSCOPY-BASED RNA IMAGING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 69 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 70 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 71 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 72 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 73 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 74 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 75 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 76 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 77 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 78 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 79 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 80 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 81 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 82 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 83 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 84 IN-SITU RNA SEQUENCING PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 85 NORTH AMERICA: IN-SITU RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 86 EUROPE: IN-SITU RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 87 ASIA PACIFIC: IN-SITU RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 88 LATIN AMERICA: IN-SITU RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 89 SINGLE-CELL RNA (SC-RNA) SEQUENCING PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 90 NORTH AMERICA: SINGLE-CELL RNA (SC-RNA) SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 91 EUROPE: SINGLE-CELL RNA (SC-RNA) SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 92 ASIA PACIFIC: SINGLE-CELL RNA (SC-RNA) SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 93 LATIN AMERICA: SINGLE-CELL RNA (SC-RNA) SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 94 OTHER RNA SEQUENCING PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 95 NORTH AMERICA: OTHER RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 96 EUROPE: OTHER RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 97 ASIA PACIFIC: OTHER RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 98 LATIN AMERICA: OTHER RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 99 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR OTHER TRANSCRIPTOMICS TECHNIQUES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 100 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR OTHER TRANSCRIPTOMICS TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 101 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR OTHER TRANSCRIPTOMICS TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 102 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR OTHER TRANSCRIPTOMICS TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 103 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR OTHER TRANSCRIPTOMICS TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 104 SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 105 SPATIAL GENOMICS PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 106 NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 107 EUROPE: SPATIAL GENOMICS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 108 ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 109 LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 110 SPATIAL GENOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 111 NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 112 EUROPE: SPATIAL GENOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 113 ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 114 LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 115 SPATIAL GENOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 116 NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 117 EUROPE: SPATIAL GENOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 118 ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 119 LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 120 SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 121 SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 122 NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 123 EUROPE: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 124 ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 125 LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 126 MICRODISSECTION-BASED SEQUENCING PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 127 NORTH AMERICA: MICRODISSECTION-BASED SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 128 EUROPE: MICRODISSECTION-BASED SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 129 ASIA PACIFIC: MICRODISSECTION-BASED SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 130 LATIN AMERICA: MICRODISSECTION-BASED SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 131 CHROMATIN ACCESSIBILITY SEQUENCING PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 132 NORTH AMERICA: CHROMATIN ACCESSIBILITY SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 133 EUROPE: CHROMATIN ACCESSIBILITY SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 134 ASIA PACIFIC: CHROMATIN ACCESSIBILITY SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 135 LATIN AMERICA: CHROMATIN ACCESSIBILITY SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 136 OTHER GENOMIC SEQUENCING PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 137 NORTH AMERICA: OTHER GENOMIC SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 138 EUROPE: OTHER GENOMIC SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 139 ASIA PACIFIC: OTHER GENOMIC SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 140 LATIN AMERICA: OTHER GENOMIC SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 141 SPATIAL GENOMICS PRODUCTS MARKET FOR OTHER SPATIAL GENOMIC TECHNIQUES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 142 NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR OTHER SPATIAL GENOMIC TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 143 EUROPE: SPATIAL GENOMICS PRODUCTS MARKET FOR OTHER SPATIAL GENOMIC TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 144 ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET FOR OTHER SPATIAL GENOMIC TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 145 LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR OTHER SPATIAL GENOMIC TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 146 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 147 SPATIAL GENOMICS & TRANSCRIPTOMICS SAMPLE PREPARATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 148 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 149 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 150 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 151 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 152 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SEQUENCING & ANALYTICAL SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 153 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SEQUENCING & ANALYTICAL SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 154 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SEQUENCING & ANALYTICAL SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 155 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SEQUENCING & ANALYTICAL SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 156 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SEQUENCING & ANALYTICAL SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 157 SPATIAL GENOMICS & TRANSCRIPTOMICS DATA VISUALIZATION & ANALYSIS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 158 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS DATA VISUALIZATION & ANALYSIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 159 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS DATA VISUALIZATION & ANALYSIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 160 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS DATA VISUALIZATION & ANALYSIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 161 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS DATA VISUALIZATION & ANALYSIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 162 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 163 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 164 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 165 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 166 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 167 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 168 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 169 TRANSLATIONAL RESEARCH MARKET FOR CANCER, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 170 NORTH AMERICA: TRANSLATIONAL RESEARCH MARKET FOR CANCER, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 171 EUROPE: TRANSLATIONAL RESEARCH MARKET FOR CANCER, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 172 ASIA PACIFIC: TRANSLATIONAL RESEARCH MARKET FOR CANCER, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 173 LATIN AMERICA: TRANSLATIONAL RESEARCH MARKET FOR CANCER, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 174 TRANSLATIONAL RESEARCH MARKET FOR IMMUNOLOGY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 175 NORTH AMERICA: TRANSLATIONAL RESEARCH MARKET FOR IMMUNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 176 EUROPE: TRANSLATIONAL RESEARCH MARKET FOR IMMUNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 177 ASIA PACIFIC: TRANSLATIONAL RESEARCH MARKET FOR IMMUNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 178 LATIN AMERICA: TRANSLATIONAL RESEARCH MARKET FOR IMMUNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 179 TRANSLATIONAL RESEARCH MARKET FOR NEUROSCIENCE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 180 NORTH AMERICA: TRANSLATIONAL RESEARCH MARKET FOR NEUROSCIENCE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 181 EUROPE: TRANSLATIONAL RESEARCH MARKET FOR NEUROSCIENCE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 182 ASIA PACIFIC: TRANSLATIONAL RESEARCH MARKET FOR NEUROSCIENCE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 183 LATIN AMERICA: TRANSLATIONAL RESEARCH MARKET FOR NEUROSCIENCE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 184 TRANSLATIONAL RESEARCH MARKET FOR INFECTIOUS DISEASES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 185 NORTH AMERICA: TRANSLATIONAL RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 186 EUROPE: TRANSLATIONAL RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 187 ASIA PACIFIC: TRANSLATIONAL RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 188 LATIN AMERICA: TRANSLATIONAL RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 189 TRANSLATIONAL RESEARCH MARKET FOR OTHER DISEASES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 190 NORTH AMERICA: TRANSLATIONAL RESEARCH MARKET FOR OTHER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 191 EUROPE: TRANSLATIONAL RESEARCH MARKET FOR OTHER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 192 ASIA PACIFIC: TRANSLATIONAL RESEARCH MARKET FOR OTHER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 193 LATIN AMERICA: TRANSLATIONAL RESEARCH MARKET FOR OTHER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 194 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 195 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 196 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 197 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 198 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 199 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 200 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 201 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 202 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 203 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 204 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 205 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 206 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 207 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 208 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 209 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 210 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 211 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 212 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 213 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 214 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 215 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 216 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 217 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 218 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 219 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 220 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 221 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 222 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 223 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 224 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 225 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 226 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 227 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 228 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 229 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 230 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 231 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 232 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 233 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 234 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 235 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 236 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 237 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 238 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 239 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 240 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 241 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 242 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 243 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 244 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 245 NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 246 NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 247 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 248 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 249 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 250 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 251 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 252 NORTH AMERICA: KEY MACROINDICATORS
  • TABLE 253 US: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 254 US: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 255 US: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 256 US: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 257 US: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 258 US: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 259 US: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 260 US: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 261 US: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 262 US: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 263 US: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 264 US: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 265 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 266 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 267 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 268 CANADA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 269 CANADA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 270 CANADA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 271 CANADA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 272 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 273 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 274 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 275 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 276 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 277 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 278 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 279 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 280 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 281 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 282 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 283 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 284 EUROPE: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 285 EUROPE: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 286 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 287 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 288 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 289 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 290 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 291 EUROPE: KEY MACROINDICATORS
  • TABLE 292 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 293 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 294 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 295 GERMANY: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 296 GERMANY: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 297 GERMANY: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 298 GERMANY: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 299 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 300 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 301 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 302 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 303 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 304 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 305 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 306 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 307 UK: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 308 UK: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 309 UK: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 310 UK: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 311 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 312 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 313 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 314 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 315 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 316 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 317 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 318 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 319 FRANCE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 320 FRANCE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 321 FRANCE: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 322 FRANCE: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 323 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 324 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 325 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 326 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 327 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 328 ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 329 ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 330 ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 331 ITALY: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 332 ITALY: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 333 ITALY: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 334 ITALY: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 335 ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 336 ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 337 ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 338 ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 339 ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 340 SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 341 SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 342 SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 343 SPAIN: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 344 SPAIN: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 345 SPAIN: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 346 SPAIN: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 347 SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 348 SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 349 SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 350 SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 351 SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 352 REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 353 REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 354 REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 355 REST OF EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 356 REST OF EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 357 REST OF EUROPE: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 358 REST OF EUROPE: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 359 REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 360 REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 361 REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 362 REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 363 REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 364 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 365 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 366 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 367 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 368 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 369 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 370 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 371 ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 372 ASIA PACIFIC: SPATIAL GENOMICS MARKET PRODUCTS FOR GENOMIC SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 373 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 374 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 375 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 376 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 377 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 378 ASIA PACIFIC: KEY MACROINDICATORS
  • TABLE 379 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 380 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 381 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 382 CHINA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 383 CHINA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 384 CHINA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 385 CHINA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 386 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 387 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 388 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 389 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 390 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 391 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 392 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 393 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 394 JAPAN: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 395 JAPAN: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 396 JAPAN: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 397 JAPAN: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 398 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 399 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 400 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 401 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 402 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 403 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 404 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 405 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 406 INDIA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 407 INDIA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 408 INDIA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 409 INDIA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 410 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 411 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 412 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 413 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 414 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 415 SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 416 SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 417 SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 418 SOUTH KOREA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 419 SOUTH KOREA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 420 SOUTH KOREA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 421 SOUTH KOREA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 422 SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 423 SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 424 SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 425 SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 426 SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 427 AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 428 AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 429 AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 430 AUSTRALIA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 431 AUSTRALIA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 432 AUSTRALIA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 433 AUSTRALIA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 434 AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 435 AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 436 AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 437 AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 438 AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 439 REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 440 REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 441 REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 442 REST OF ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 443 REST OF ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 444 REST OF ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 445 REST OF ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 446 REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 447 REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 448 REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 449 REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 450 REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 451 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 452 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 453 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 454 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 455 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 456 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 457 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 458 LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 459 LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 460 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 461 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 462 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 463 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 464 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 465 LATIN AMERICA: KEY MACROINDICATORS
  • TABLE 466 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 467 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 468 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 469 BRAZIL: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 470 BRAZIL: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 471 BRAZIL: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 472 BRAZIL: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 473 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 474 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 475 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 476 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 477 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 478 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 479 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 480 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 481 MEXICO: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 482 MEXICO: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 483 MEXICO: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 484 MEXICO: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 485 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 486 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 487 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 488 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 489 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 490 REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 491 REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 492 REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 493 REST OF LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 494 REST OF LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 495 REST OF LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 496 REST OF LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 497 REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 498 REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 499 REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 500 REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 501 REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 502 MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 503 MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 504 MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 505 MIDDLE EAST: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 506 MIDDLE EAST: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 507 MIDDLE EAST: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 508 MIDDLE EAST: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 509 MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 510 MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 511 MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 512 MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 513 MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 514 MIDDLE EAST: KEY MACROINDICATORS
  • TABLE 515 AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 516 AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 517 AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 518 AFRICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 519 AFRICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 520 AFRICA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 521 AFRICA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 522 AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 523 AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 524 AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 525 AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 526 AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 527 AFRICA: KEY MACROINDICATORS
  • TABLE 528 STRATEGIES ADOPTED BY KEY PLAYERS IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, 2021−2024
  • TABLE 529 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET: DEGREE OF COMPETITION
  • TABLE 530 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: REGION FOOTPRINT
  • TABLE 531 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: OFFERING FOOTPRINT
  • TABLE 532 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: TECHNIQUE FOOTPRINT
  • TABLE 533 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: APPLICATION FOOTPRINT
  • TABLE 534 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: KEY STARTUPS/SMES
  • TABLE 535 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 536 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024
  • TABLE 537 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 538 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: EXPANSIONS, JANUARY 2021–NOVEMBER 2024
  • TABLE 539 10X GENOMICS: COMPANY OVERVIEW
  • TABLE 540 10X GENOMICS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 541 10X GENOMICS: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024
  • TABLE 542 10X GENOMICS: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 543 10X GENOMICS: EXPANSIONS, JANUARY 2021–NOVEMBER 2024
  • TABLE 544 BIO-TECHNE: COMPANY OVERVIEW
  • TABLE 545 BIO-TECHNE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 546 BIO-TECHNE: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024
  • TABLE 547 BIO-TECHNE: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 548 BIO-TECHNE: EXPANSIONS, JANUARY 2021–NOVEMBER 2024
  • TABLE 549 NANOSTRING TECHNOLOGIES, INC. (BRUKER SPATIAL BIOLOGY, INC.): COMPANY OVERVIEW
  • TABLE 550 NANOSTRING TECHNOLOGIES, INC. (BRUKER SPATIAL BIOLOGY, INC.): PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 551 NANOSTRING TECHNOLOGIES, INC. (BRUKER SPATIAL BIOLOGY, INC.): PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024
  • TABLE 552 NANOSTRING TECHNOLOGIES, INC. (BRUKER SPATIAL BIOLOGY, INC.): DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 553 STANDARD BIOTOOLS: COMPANY OVERVIEW
  • TABLE 554 STANDARD BIOTOOLS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 555 STANDARD BIOTOOLS: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024
  • TABLE 556 STANDARD BIOTOOLS: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 557 ILLUMINA, INC.: COMPANY OVERVIEW
  • TABLE 558 ILLUMINA, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 559 ILLUMINA, INC.: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024
  • TABLE 560 ILLUMINA, INC.: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 561 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
  • TABLE 562 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 563 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024
  • TABLE 564 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 565 AKOYA BIOSCIENCES, INC.: COMPANY OVERVIEW
  • TABLE 566 AKOYA BIOSCIENCES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 567 AKOYA BIOSCIENCES, INC.: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024
  • TABLE 568 AKOYA BIOSCIENCES, INC.: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 569 AKOYA BIOSCIENCES, INC.: EXPANSIONS, JANUARY 2021–NOVEMBER 2024
  • TABLE 570 VISIOPHARM A/S: COMPANY OVERVIEW
  • TABLE 571 VISIOPHARM A/S: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 572 VISIOPHARM A/S: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024
  • TABLE 573 VISIOPHARM A/S: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 574 DANAHER CORPORATION: COMPANY OVERVIEW
  • TABLE 575 DANAHER CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 576 DANAHER CORPORATION: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 577 SEVEN BRIDGES GENOMICS: COMPANY OVERVIEW
  • TABLE 578 SEVEN BRIDGES GENOMICS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 579 SEVEN BRIDGES GENOMICS: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 580 REVVITY: COMPANY OVERVIEW
  • TABLE 581 REVVITY: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 582 REVVITY: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 583 REVVITY: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 584 VIZGEN INC.: COMPANY OVERVIEW
  • TABLE 585 VIZGEN INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 586 VIZGEN INC.: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024
  • TABLE 587 VIZGEN INC.: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 588 VERACYTE, INC.: COMPANY OVERVIEW
  • TABLE 589 VERACYTE, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 590 NATERA, INC.: COMPANY OVERVIEW
  • TABLE 591 NATERA, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 592 NATERA, INC.: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024
  • TABLE 593 NATERA, INC.: EXPANSIONS, JANUARY 2021–NOVEMBER 2024
  • TABLE 594 MACROGEN INC.: COMPANY OVERVIEW
  • TABLE 595 MACROGEN INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 596 MACROGEN, INC.: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 597 MILTENYI BIOTEC: COMPANY OVERVIEW
  • TABLE 598 MILTENYI BIOTEC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 599 MILTENYI BIOTEC: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 600 BIOMARKER TECHNOLOGIES (BMKGENE): COMPANY OVERVIEW
  • TABLE 601 ULTIVUE, INC: COMPANY OVERVIEW
  • TABLE 602 RARECYTE, INC.: COMPANY OVERVIEW
  • TABLE 603 S2 GENOMICS, INC.: COMPANY OVERVIEW
  • TABLE 604 ADMERA HEALTH: COMPANY OVERVIEW
  • TABLE 605 SONY BIOTECHNOLOGY INC.: COMPANY OVERVIEW
  • TABLE 606 CANTATA BIO: COMPANY OVERVIEW
  • TABLE 607 NUCLEAI, INC.: COMPANY OVERVIEW
  • TABLE 608 VISIKOL, INC.: COMPANY OVERVIEW
  • TABLE 609 IONPATH, INC.: COMPANY OVERVIEW
  • TABLE 610 BIOSPYDER, INC.: COMPANY OVERVIEW
  • TABLE 611 SINGULAR GENOMICS SYSTEMS, INC.: COMPANY OVERVIEW
  • TABLE 612 LUNAPHORE TECHNOLOGIES SA.: COMPANY OVERVIEW
  • TABLE 613 REBUS BIOSYSTEMS, INC.: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: SEGMENTS AND REGIONS CONSIDERED
  • FIGURE 2 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: YEARS CONSIDERED
  • FIGURE 3 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: RESEARCH DESIGN
  • FIGURE 4 BREAKDOWN OF PRIMARIES: BY RESPONDENT, DESIGNATION, AND REGION
  • FIGURE 5 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
  • FIGURE 6 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
  • FIGURE 7 MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS-BASED ESTIMATION, 2023 (PRODUCTS MARKET)
  • FIGURE 8 SERVICES MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS-BASED ESTIMATION (2023)
  • FIGURE 9 PRODUCTS MARKET REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF ILLUMINA, INC. (2023)
  • FIGURE 10 MARKET SIZE VALIDATION FROM PRIMARIES
  • FIGURE 11 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH (PRODUCT)
  • FIGURE 12 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET: CAGR PROJECTIONS (2024–2029)
  • FIGURE 13 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET: CAGR PROJECTIONS (2024–2029)
  • FIGURE 14 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET: DATA TRIANGULATION
  • FIGURE 15 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 17 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 18 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 19 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 20 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 21 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET: REGIONAL SNAPSHOT
  • FIGURE 22 HIGH R&D INVESTMENTS AND INCREASED FOCUS ON DRUG DISCOVERY & DEVELOPMENT TO DRIVE MARKET
  • FIGURE 23 CHINA AND SPATIAL TRANSCRIPTOMICS COMMANDED LARGEST MARKET SHARE IN 2023
  • FIGURE 24 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 25 ACADEMIC & RESEARCH INSTITUTES ACCOUNTED FOR LARGEST SHARE IN SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET 2023
  • FIGURE 26 ACADEMIC & RESEARCH INSTITUTES ACCOUNTED FOR LARGEST SHARE IN SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET IN 2023
  • FIGURE 27 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 28 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: TRENDS/ DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
  • FIGURE 29 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY KEY PLAYER, 2021–2023 (USD)
  • FIGURE 30 AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER, 2021–2023 (USD)
  • FIGURE 31 AVERAGE SELLING PRICE OF KEY PRODUCTS, BY REGION, 2023 (USD)
  • FIGURE 32 AVERAGE SELLING PRICE OF KEY PRODUCTS, BY REGION, 2022 (USD)
  • FIGURE 33 AVERAGE SELLING PRICE OF KEY PRODUCTS, BY REGION, 2021 (USD)
  • FIGURE 34 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 35 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 36 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 37 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: NUMBER OF PATENT APPLICANTS/OWNERS IN LAST 10 YEARS (2014–2024)
  • FIGURE 38 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 39 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
  • FIGURE 40 KEY BUYING CRITERIA, BY END USER (PRODUCT)
  • FIGURE 41 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: INVESTMENT & FUNDING SCENARIO, 2021–2023 (USD MILLION)
  • FIGURE 42 IMPACT OF AI/GEN AI ON SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET
  • FIGURE 43 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SNAPSHOT
  • FIGURE 44 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SNAPSHOT
  • FIGURE 45 REVENUE ANALYSIS OF KEY PLAYERS IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, 2019−2023
  • FIGURE 46 MARKET SHARE ANALYSIS OF SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, 2023
  • FIGURE 47 RANKING OF KEY PLAYERS IN SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, 2023
  • FIGURE 48 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 49 EV/EBITDA OF KEY PLAYERS
  • FIGURE 50 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 51 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 52 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPANY FOOTPRINT
  • FIGURE 53 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 54 10X GENOMICS: COMPANY SNAPSHOT
  • FIGURE 55 BIO-TECHNE: COMPANY SNAPSHOT
  • FIGURE 56 NANOSTRING TECHNOLOGIES, INC. (BRUKER SPATIAL BIOLOGY, INC.): COMPANY SNAPSHOT
  • FIGURE 57 STANDARD BIOTOOLS: COMPANY SNAPSHOT
  • FIGURE 58 ILLUMINA, INC.: COMPANY SNAPSHOT
  • FIGURE 59 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
  • FIGURE 60 AKOYA BIOSCIENCES, INC.: COMPANY SNAPSHOT
  • FIGURE 61 DANAHER CORPORATION: COMPANY SNAPSHOT
  • FIGURE 62 REVVITY: COMPANY SNAPSHOT
  • FIGURE 63 NATERA, INC.: COMPANY SNAPSHOT
  • FIGURE 64 MACROGEN INC.: COMPANY SNAPSHOT

This study on the spatial genomics & transcriptomics market employed secondary sources, directories, and databases to gather pertinent information. To gather and validate important qualitative and quantitative data and evaluate market growth prospects, in-depth interviews were conducted with many primary respondents including key industry participants, subject-matter experts (SMEs), C-level executives from key market players, and industry consultants. After estimating the spatial genomics & transcriptomics market using several research strategies, the size of the final market was obtained by triangulating data from primary research.

Secondary Research

The secondary sources referred to for this research study include publications from government sources, such as World Health Organization (WHO), National Institutes of Health (NIH), Organisation for Economic Co-operation and Development (OECD), International Agency for Research on Cancer (IARC), Research!America, Genome Canada, GenomeWeb, South African Medical Research Council (SAMRC), Wellcome Sanger Institute, Genome Research Limited, Labiotech.eu, R&D World Magazine, India Brand Equity Foundation (IBEF), Biotechnology Innovation Organization (BIO), National Center for Biotechnology Information (NCBI), BioPharm International, EvaluatePharma, ScienceDirect, Eurostat. Secondary sources include corporate and regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global spatial genomics & transcriptomics market, which was validated through primary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global spatial genomics & transcriptomics market scenario through secondary research. Several primary interviews were conducted with market experts from the supply side, such as C-level and D-level executives, operational managers, marketing & sales managers of key manufacturers, distributors, and channel partners of companies providing gene editing products and services; experts from the demand side, such as personnel from pharmaceutical & biotechnology companies, Academic & research institutes, clinical diagnostic laboratories, and CROs & CDMOs. These interviews were conducted across six major regions, including North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

The following is a breakdown of the primary respondents:

Spatial Genomics & Transcriptomics Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the spatial genomics & transcriptomics market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Bottom-up Approach

  • The key players in the industry and market have been identified through extensive secondary research.
  • The revenues generated from the spatial genomics & transcriptomics market business of leading players have been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Top-down Approach

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

Spatial Genomics & Transcriptomics Market

Data Triangulation

To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

The spatial genomics & transcriptomics market, as covered within the scope of this report, includes products, technologies, and services that facilitate spatial genomics & transcriptomics across various applications. Spatial genomics and transcriptomics are pioneering technologies that allow scientists to measure the gene activity in a tissue sample and map the site of the activity. Spatial transcriptomics helps spatially resolve RNA-seq data and all mRNAs in individual tissue sections. The technology is presently used in translational research and can be used in clinical diagnosis in the future. Spatial genomics also helps map gene expressions across human tissues.

Stakeholders

  • Manufacturers and distributors of spatial genomics and transcriptomics products
  • Spatial genomics and transcriptomics service providers
  • Pharmaceutical and biotechnology companies
  • Contract research organizations (CROs)
  • Contract Development & Manufacturing Organizations (CDMOs)
  • Market research and consulting firms
  • R&D centers
  • Researchers and scientists
  • Academic & research institutes
  • Market Research and Consulting Firms
  • Regulatory Agencies
  • Venture Capitalists
  • Government Organizations
  • Industry Associations and Professional Societies
  • Diagnostic companies

Report Objectives

  • To define, describe, segment, and forecast the spatial genomics & transcriptomics market based on offering, technique, application, type (service), end user (product), end user (service), and region
  • To provide detailed information about the factors influencing market growth, such as drivers, restraints, opportunities, and challenges
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall gene editing market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments concerning six main regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa.
  • To strategically profile the key players in the global spatial genomics & transcriptomics market and comprehensively analyze their core competencies2 and market rankings.
  • To track and analyze competitive developments, such as product & service launches, acquisitions, collaborations, expansions, and partnerships in the gene editing market.
  • To profile the key players in the global spatial genomics & transcriptomics market and comprehensively analyze their product and services portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as product & service launches, expansions, agreements, and collaborations in the spatial genomics & transcriptomics market
  • To benchmark players within the spatial genomics & transcriptomics market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business and service strategy.

Previous Versions of this Report

Spatial Genomics & Transcriptomics Market by Technique (Spatial Transcriptomics, Spatial Genomics), Product (Instruments, Consumables, Software), Application (Translational Research, Drug Discovery), End User, Global Forecast to 2027

Report Code BT 7790
Published in Dec, 2022, By MarketsandMarkets™

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Spatial Genomics & Transcriptomics Market

+1-888600-6441

Corporate Office Hours

+1-888600-6441

US/Can Toll Free

+44-800-368-9399

UK Office Hours

©2024 Marketsandmarkets Research Private Ltd. All Rights Reserved.

DMCA.com Protection Status